Document is current

Any future updates will be listed below

Unlocking potential topoisomerase-II inhibitors: ligand-based drug design pipeline integrating pharmacophore mapping, virtual screening, molecular docking, and ADMET profiling

Crossref DOI link: https://doi.org/10.1007/s11696-025-04103-7

Published Online: 2025-05-25

Published Print: 2025-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark